Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

Author： Johansson Gunnar  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.7, 2006-01, pp. : 695-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy

By Santus Pierachille   Giovannelli Francesca   Di Marco Fabiano   Centanni Stefano  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 257-267

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/Formoterol: A Review of its Use as Maintenance and Reliever Inhalation Therapy in Asthma

By McCormack Paul L.   Lyseng-Williamson Katherine A.  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2407-2431

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Treatment Comparison of Budesonide/Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study

By Kuna Piotr  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 565-579

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite